Benefit Co. Catamaran Inks $410M Rival Buy As Earnings Soar

Law360, New York (August 1, 2013, 1:25 PM EDT) -- Pharmacy benefit manager Catamaran Corp. will put up $409.5 million to absorb Restat LLC, one of its biggest privately owned rivals, to build up its client base and expand its core business of administering health plans and drug benefits for employers, it said Thursday.

The deal joins two businesses whose aims and operations sync up well, and also marks Catamaran's first pickup of a company that is not already a client or partner — opening Catamaran to an entirely new field of customers, Catamaran Chairman and...
To view the full article, register now.